Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies.

Sordo L, Barrio G, Bravo MJ, Indave BI, Degenhardt L, Wiessing L, Ferri M, Pastor-Barriuso R.

BMJ. 2017 Apr 26;357:j1550. doi: 10.1136/bmj.j1550. Review.

2.

Differences between men and women in substance use: the role of educational level and employment status.

Teixidó-Compañó E, Espelt A, Sordo L, Bravo MJ, Sarasa-Renedo A, Indave BI, Bosque-Prous M, Brugal MT.

Gac Sanit. 2018 Jan - Feb;32(1):41-47. doi: 10.1016/j.gaceta.2016.12.017. Epub 2017 Mar 18.

3.

Maximal isometric muscle strength values obtained By hand-held dynamometry in children between 6 and 15 years of age.

Escobar RG, Munoz KT, Dominguez A, Banados P, Bravo MJ.

Muscle Nerve. 2017 Jan;55(1):16-22. doi: 10.1002/mus.25180. Epub 2016 Oct 24.

PMID:
27158770
4.

Estimating average alcohol consumption in the population using multiple sources: the case of Spain.

Sordo L, Barrio G, Bravo MJ, Villalbí JR, Espelt A, Neira M, Regidor E.

Popul Health Metr. 2016 Jun 2;14:21. doi: 10.1186/s12963-016-0090-4. eCollection 2016.

5.

Job Loss, Unemployment and the Incidence of Hazardous Drinking during the Late 2000s Recession in Europe among Adults Aged 50-64 Years.

Bosque-Prous M, Espelt A, Sordo L, Guitart AM, Brugal MT, Bravo MJ.

PLoS One. 2015 Oct 7;10(10):e0140017. doi: 10.1371/journal.pone.0140017. eCollection 2015.

6.

Effect of immigration background and country-of-origin contextual factors on adolescent substance use in Spain.

Sarasa-Renedo A, Sordo L, Pulido J, Guitart A, González-González R, Hoyos J, Bravo MJ, Barrio G.

Drug Alcohol Depend. 2015 Aug 1;153:124-34. doi: 10.1016/j.drugalcdep.2015.05.040. Epub 2015 Jun 6.

PMID:
26094187
7.

High hepatitis C virus prevalence and incidence in a community cohort of young heroin injectors in a context of extensive harm reduction programmes.

Vallejo F, Barrio G, Brugal MT, Pulido J, Toro C, Sordo L, Espelt A, Bravo MJ; Itinere Project Group.

J Epidemiol Community Health. 2015 Jun;69(6):599-603. doi: 10.1136/jech-2014-205070. Epub 2015 Apr 13.

PMID:
25870164
8.

Potential bias due to outcome-related loss to follow-up in cohort studies on incidence of drug injection: systematic review and meta-analysis.

Sordo L, Bravo MJ, Barrio G, Indave BI, Degenhardt L, Pastor-Barriuso R.

Addiction. 2015 Aug;110(8):1247-57. doi: 10.1111/add.12940. Epub 2015 Jun 2. Review.

PMID:
25845977
9.

An example of the usefulness of joinpoint trend analysis for assessing changes in traffic safety policies.

Barrio G, Pulido J, Bravo MJ, Lardelli-Claret P, Jiménez-Mejías E, de la Fuente L.

Accid Anal Prev. 2015 Feb;75:292-7. doi: 10.1016/j.aap.2014.12.010. Epub 2014 Dec 24.

PMID:
25543100
10.

[Research methods on alcohol-related harm in the population].

Indave BI, Sordo L, Pulido J, Vallejo F, Sarasa-Renedo A, Bravo MJ.

Rev Esp Salud Publica. 2014 Aug;88(4):447-68. doi: 10.4321/S1135-57272014000400003. Review. Spanish.

11.

Has health in Spain been declining since the economic crisis?

Regidor E, Barrio G, Bravo MJ, de la Fuente L.

J Epidemiol Community Health. 2014 Mar;68(3):280-2. doi: 10.1136/jech-2013-202944. Epub 2013 Oct 23.

PMID:
24153246
12.

Mortality risk factors and excess mortality in a cohort of cocaine users admitted to drug treatment in Spain.

de la Fuente L, Molist G, Espelt A, Barrio G, Guitart A, Bravo MJ, Brugal MT; Spanish Working Group for the Study of Mortality among Drug Users.

J Subst Abuse Treat. 2014 Feb;46(2):219-26. doi: 10.1016/j.jsat.2013.07.001. Epub 2013 Sep 12.

PMID:
24035555
13.

Non-fatal opioid overdose and major depression among street-recruited young heroin users.

Chahua M, Sordo L, Barrio G, Domingo-Salvany A, Brugal MT, Molist G, de la Fuente L, Bravo MJ; ITINERE Project Group.

Eur Addict Res. 2014;20(1):1-7. doi: 10.1159/000346787. Epub 2013 Aug 1.

PMID:
23921233
14.

Trends of heroin use and heroin injection epidemics in Europe: findings from the EMCDDA treatment demand indicator (TDI).

Barrio G, Montanari L, Bravo MJ, Guarita B, de la Fuente L, Pulido J, Vicente J.

J Subst Abuse Treat. 2013 Jul;45(1):19-30. doi: 10.1016/j.jsat.2012.11.002. Epub 2013 Feb 23.

PMID:
23462151
15.

Mortality in a cohort of young primary cocaine users: controlling the effect of the riskiest drug-use behaviors.

Barrio G, Molist G, de la Fuente L, Fernández F, Guitart A, Bravo MJ, Brugal MT; Itinere Working Group.

Addict Behav. 2013 Mar;38(3):1601-4. doi: 10.1016/j.addbeh.2012.10.007. Epub 2012 Oct 22.

PMID:
23254204
16.

HCV seroconversion among never-injecting heroin users at baseline: no predictors identified other than starting injection.

Bravo MJ, Vallejo F, Barrio G, Brugal MT, Molist G, Pulido J, Sordo L, de la Fuente L; ITINERE Project Group.

Int J Drug Policy. 2012 Sep;23(5):415-9. doi: 10.1016/j.drugpo.2012.02.002. Epub 2012 Mar 14.

PMID:
22421554
17.

Association between cannabis use and non-traffic injuries.

Barrio G, Jiménez-Mejías E, Pulido J, Lardelli-Claret P, Bravo MJ, de la Fuente L.

Accid Anal Prev. 2012 Jul;47:172-6. doi: 10.1016/j.aap.2012.01.002. Epub 2012 Feb 2.

PMID:
22405246
18.

Harm reduction interventions for drug injectors or heroin users in Spain: expanding coverage as the storm abates.

Barrio G, Bravo MJ, Brugal MT, Díez M, Regidor E, Belza MJ, de la Fuente L; Itinere Working Group.

Addiction. 2012 Jun;107(6):1111-22. doi: 10.1111/j.1360-0443.2011.03759.x. Epub 2012 Feb 11.

PMID:
22151686
19.

Quantitative real-time polymerase chain reaction improves conventional microbiological diagnosis in an outbreak of brucellosis due to ingestion of unpasteurized goat cheese.

Colmenero JD, Clavijo E, Morata P, Bravo MJ, Queipo-Ortuño MI.

Diagn Microbiol Infect Dis. 2011 Nov;71(3):294-6. doi: 10.1016/j.diagmicrobio.2011.06.016. Epub 2011 Aug 19.

PMID:
21855249
20.

Cannabis use and traffic injuries.

Pulido J, Barrio G, Lardelli P, Bravo MJ, Brugal MT, Espelt A, de la Fuente L, Pulido J, Barrio G, Lardelli P, Bravo MJ, Brugal MT, Espelt A, de la Fuente L, Ambrós M, Belza MJ, Castellano Y, Domingo-Salvany A, Fernández F, Molist G, Sánchez-Niubó A, Santos S, Sordo L, Vallejo F; Itínere Project Group.

Epidemiology. 2011 Jul;22(4):609-10. doi: 10.1097/EDE.0b013e31821db0c2. No abstract available.

PMID:
21642783
21.

Association between cannabis and cocaine use, traffic injuries and use of protective devices.

Pulido J, Barrio G, Lardelli P, Bravo MJ, Regidor E, de la Fuente L.

Eur J Public Health. 2011 Dec;21(6):753-5. doi: 10.1093/eurpub/ckq161. Epub 2010 Nov 10.

PMID:
21071390
22.

Infrequent opioid overdose risk reduction behaviours among young adult heroin users in cities with wide coverage of HIV prevention programmes.

Neira-León M, Barrio G, Bravo MJ, Brugal MT, de la Fuente L, Domingo-Salvany A, Pulido J, Santos S; Project Itinere Group.

Int J Drug Policy. 2011 Jan;22(1):16-25. doi: 10.1016/j.drugpo.2010.06.003. Epub 2010 Aug 30.

PMID:
20800462
23.

Methadone maintenance treatment: a protective factor for cocaine injection in a street-recruited cohort of heroin users.

Bravo MJ, Llorens N, Barrio G, Brugal MT, Santos S, Sordo L, de la Fuente L; Itinere Project Group.

Drug Alcohol Depend. 2010 Nov 1;112(1-2):62-8. doi: 10.1016/j.drugalcdep.2010.05.014. Epub 2010 Jun 29.

PMID:
20591582
24.

Estimating the prevalence of drug injection using a multiplier method based on a register of new HIV diagnoses.

Barrio Anta G, Oliva J, Bravo MJ, De Mateo S, Domingo-Salvany A; Itinere Working Group.

Eur J Public Health. 2011 Oct;21(5):646-8. doi: 10.1093/eurpub/ckq076. Epub 2010 Jun 14.

PMID:
20551045
25.

[Classification of illicit drug-induced deaths in Spain: toward the adoption of the European standard criteria].

Santos S, Molist G, Barrio G, Pulido J, Bravo MJ, Fernández-Cuenca R, de la Fuente L.

Gac Sanit. 2010 Jul-Aug;24(4):309-13. doi: 10.1016/j.gaceta.2010.04.002. Epub 2010 May 31. Spanish.

26.

Injecting, sexual risk behaviors and HIV infection in young cocaine and heroin users in Spain.

Brugal MT, Pulido J, Toro C, de la Fuente L, Bravo MJ, Ballesta R, Soriano V, Barrio G, Vallejo F, Domingo-Salvany A, Castellano Y; Project Itinere Group.

Eur Addict Res. 2009;15(3):171-8. doi: 10.1159/000220345. Epub 2009 Jun 5.

PMID:
19506378
27.

The role of injection versus socioeconomic factors in hepatitis A virus infection among young heroin users: Implications for vaccination policies.

Luquero FJ, Vallejo F, Fuente Lde L, Toro C, Brugal MT, Bravo MJ, Soriano V, Barrio G, Pulido J; Project Itinere Group.

Vaccine. 2009 May 5;27(20):2674-9. doi: 10.1016/j.vaccine.2009.02.056. Epub 2009 Feb 24.

PMID:
19428878
28.

[Recruitment methodology and characteristics of a cohort of young regular cocaine users in three Spanish cities (the Itinere-cocaine Project)].

Pulido J, Brugal MT, de la Fuente L, Ballesta R, Barrio G, Bravo MJ, Domingo-Salvany A, Castellano Y, Fernández F; Grupo del Proyecto Itínere.

Gac Sanit. 2009 May-Jun;23(3):200-7. doi: 10.1016/j.gaceta.2008.05.003. Epub 2009 Feb 27. Spanish.

29.

Use of supervised injection facilities and injection risk behaviours among young drug injectors.

Bravo MJ, Royuela L, De la Fuente L, Brugal MT, Barrio G, Domingo-Salvany A; Itínere Project Group.

Addiction. 2009 Apr;104(4):614-9. doi: 10.1111/j.1360-0443.2008.02474.x. Epub 2009 Feb 10.

PMID:
19215603
30.

Access to sterile syringes among young drug injectors in Madrid and Barcelona and its association with risk behaviour.

Bravo MJ, Royuela L, Barrio G, Brugal MT, Domingo A, de la Fuente L; Itínere Project Group.

Gac Sanit. 2008 Mar-Apr;22(2):128-32.

31.

Hepatitis B vaccination: an unmet challenge in the era of harm reduction programs.

Vallejo F, Toro C, de la Fuente L, Brugal MT, Barrio G, Soriano V, Ballesta R, Bravo MJ; Project Itinere Group.

J Subst Abuse Treat. 2008 Jun;34(4):398-406. Epub 2007 Sep 14.

PMID:
17869476
32.

More free syringes, fewer drug injectors in the case of Spain.

Bravo MJ, Royuela L, Barrio G, de la Fuente L, Suarez M, Teresa Brugal M.

Soc Sci Med. 2007 Oct;65(8):1773-8. Epub 2007 Jul 19.

PMID:
17658207
33.

[More than thirty years of illicit drugs in Spain: a bitter story with some messages for the future].

de la Fuente L, Brugal MT, Domingo-Salvany A, Bravo MJ, Neira-León M, Barrio G.

Rev Esp Salud Publica. 2006 Sep-Oct;80(5):505-20. Spanish.

34.

Poor validity of self-reported HBV vaccination among young heroin users in Spain supports the policy "don't ask, draw a blood sample, vaccinate and try to schedule another visit".

de la Fuente L, Toro C, Brugal MT, Vallejo F, Soriano V, Barrio G, Ballesta R, Bravo MJ; Project Itinere Group.

J Clin Virol. 2007 Jan;38(1):87-90. Epub 2006 Nov 7.

PMID:
17088099
35.

Do young heroin users in Madrid, Barcelona and Seville have sufficient knowledge of the risk factors for unintentional opioid overdose?

Neira-León M, Barrio G, Brugal MT, de la Fuente L, Ballesta R, Bravo MJ, Silva TC, Rodríguez-Martos A; Project Itinere Group.

J Urban Health. 2006 May;83(3):477-96.

36.

[Prevalence of indirect sharing of drug-injecting paraphernalia in Galicia, Madrid, Seville and Valencia [Spain]].

Bravo MJ, Royuela L, Barrio G, Rodríguez-Arenas MA, de la Fuente L; Grupo de trabajo de Médicos del Mundo para el control de la infección por VIH y las prácticas de riesgo en inyectores de drogas.

Gac Sanit. 2004 Nov-Dec;18(6):472-8. Spanish.

37.

[Estimating mortality attributed to illegal drug use in Spain].

Brugal MT, Barrio G, Royuela L, Bravo MJ, de la Fuente L, Regidor E.

Med Clin (Barc). 2004 Dec 4;123(20):775-7. Spanish.

PMID:
15607069
38.

Reasons for selecting an initial route of heroin administration and for subsequent transitions during a severe HIV epidemic.

Bravo MJ, Barrio G, de la Fuente L, Royuela L, Domingo L, Silva T.

Addiction. 2003 Jun;98(6):749-60.

PMID:
12780363

Supplemental Content

Loading ...
Support Center